MiRNA signature predicts the response of patients with advanced lung adenocarcinoma to platinum-based treatment

被引：0
|
作者：
Xiaoyue Xu
Shaorong Yu
Wenbo Sun
Xiaobing Qin
Yan Chen
Leilei Zhou
Rui Lou
Shuchen Dong
Bo Shen
Jianzhong Wu
Jialan Zang
Haixia Cao
Meiqi Shi
Qin Zhang
Jifeng Feng
机构：
[1] Jiangsu Institute of Cancer Research,Nanjing Medical University Affiliated Cancer Hospital, Jiangsu Cancer Hospital
[2] Nanjing Medical University Affiliated Brain Hospital,Department of Neurosurgery
[3] Xuzhou First People’s Hospital,Department of Oncology, Huai’an First People’s Hospital
[4] Nanjing Medical University,Department of Oncology
[5] The First Hospital of Harbin City,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2018年 / 144卷
关键词：
Lung adenocarcinoma; MiRNA; Platinum resistance; Prediction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：431 / 438
页数：7
相关论文
共 50 条
  • [1] MiRNA signature predicts the response of patients with advanced lung adenocarcinoma to platinum-based treatment
    Xu, Xiaoyue
    Yu, Shaorong
    Sun, Wenbo
    Qin, Xiaobing
    Chen, Yan
    Zhou, Leilei
    Lou, Rui
    Dong, Shuchen
    Shen, Bo
    Wu, Jianzhong
    Zang, Jialan
    Cao, Haixia
    Shi, Meiqi
    Zhang, Qin
    Feng, Jifeng
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (03) : 431 - 438
  • [2] A Three-microRNA Signature Predicts Responses to Platinum-Based Doublet Chemotherapy in Patients with Lung Adenocarcinoma
    Saito, Motonobu
    Shiraishi, Kouya
    Matsumoto, Kenji
    Schetter, Aaron J.
    Ogata-Kawata, Hiroko
    Tsuchiya, Naoto
    Kunitoh, Hideo
    Nokihara, Hiroshi
    Watanabe, Shun-ichi
    Tsuta, Koji
    Kumamoto, Kensuke
    Takenoshita, Seiichi
    Yokota, Jun
    Harris, Curtis C.
    Kohno, Takashi
    CLINICAL CANCER RESEARCH, 2014, 20 (18) : 4784 - 4793
  • [3] An individualised signature for predicting response with concordant survival benefit for lung adenocarcinoma patients receiving platinum-based chemotherapy
    Qi, Lishuang
    Li, Yang
    Qin, Yuan
    Shi, Gengen
    Li, Tianhao
    Wang, Jiasheng
    Chen, Libin
    Gu, Yunyan
    Zhao, Wenyuan
    Guo, Zheng
    BRITISH JOURNAL OF CANCER, 2016, 115 (12) : 1513 - 1519
  • [4] An individualised signature for predicting response with concordant survival benefit for lung adenocarcinoma patients receiving platinum-based chemotherapy
    Lishuang Qi
    Yang Li
    Yuan Qin
    Gengen Shi
    Tianhao Li
    Jiasheng Wang
    Libin Chen
    Yunyan Gu
    Wenyuan Zhao
    Zheng Guo
    British Journal of Cancer, 2016, 115 : 1513 - 1519
  • [5] Combination of a three-microRNA signature and TP53 genotype predicts responses to platinum-based doublet chemotherapy in patients with lung adenocarcinoma
    Shiraishi, Kouya
    Saito, Motonobu
    Kohno, Takashi
    CANCER RESEARCH, 2015, 75 (22)
  • [6] DNA damage response deficiency signature predicts response to platinum-based therapy in ovarian cancer
    Hill, L. A.
    Mulligan, J. M.
    Deharo, S.
    Keating, K. E.
    McDyer, F. A.
    Davison, T. S.
    Gourley, C.
    Harkin, D. P.
    Kennedy, R. D.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S196 - S196
  • [7] Caspase 8 polymorphisms contribute to the prognosis of advanced lung adenocarcinoma patients after platinum-based chemotherapy
    Liu, Di
    Xu, Wen
    Ding, Xi
    Yang, Yang
    Lu, Yanlin
    Fei, Ke
    Su, Bo
    CANCER BIOLOGY & THERAPY, 2017, 18 (12) : 948 - 957
  • [8] PTEN polymorphisms contribute to clinical outcomes of advanced lung adenocarcinoma patients treated with platinum-based chemotherapy
    Yang, Yang
    Xu, Wen
    Liu, Di
    Ding, Xi
    Su, Bo
    Sun, Yifeng
    Gao, Wen
    TUMOR BIOLOGY, 2016, 37 (06) : 7785 - 7796
  • [9] KRAS Mutations Predict Response and Outcome in Advanced Lung Adenocarcinoma Patients Receiving First-Line Bevacizumab and Platinum-Based Chemotherapy
    Ghimessy, Aron Kristof
    Gellert, Aron
    Schlegl, Erzsebet
    Hegedus, Balazs
    Raso, Erzsebet
    Barbai, Tamas
    Timar, Jozsef
    Ostoros, Gyula
    Megyesfalvi, Zsolt
    Gieszer, Balazs
    Moldvay, Judit
    Renyi-Vamos, Ferenc
    Lohinai, Zoltan
    Hoda, Mir Alireza
    Klikovits, Thomas
    Klepetko, Walter
    Laszlo, Viktoria
    Dome, Balazs
    CANCERS, 2019, 11 (10)
  • [10] Functional miRNA variants affect lung cancer susceptibility and platinum-based chemotherapy response
    Fang, Chao
    Li, Xiang-Ping
    Chen, Yi-Xin
    Wu, Na-Yiyuan
    Yin, Ji-Ye
    Zhang, Wei
    Zhou, Hong-Hao
    Liu, Zhao-Qian
    JOURNAL OF THORACIC DISEASE, 2018, 10 (06) : 3329 - 3340
12345